UBA1

PF3D7_1333200 encodes the P. falciparum ubiquitin-activating enzyme (E1; variously termed PfsUba1/PfUBA1), the apex enzyme that charges ubiquitin and initiates ubiquitylation cascades essential for parasite viability (PMID:23785288, PMID:32569299). The enzyme is biochemically active in vitro and partitions between two functional pools: an apicoplast-associated form required for import of nuclear-encoded plastid proteins, whose conditional ablation blocks organellar protein import and kills the parasite (PMID:19502583, PMID:23785288), and a cytosolic form that supplies activated ubiquitin to the parasite ERAD system (PMID:22912882). During blood-stage development the enzyme is essential for the final differentiation of schizonts to merozoites, with conditional deletion arresting nuclear division and intracellular merozoite formation (PMID:32569299). Recombinant enzyme is potently inhibited by MLN7243 (TAK-243), and E1 activity sits upstream of the polyubiquitinated protein pool whose accumulation drives dihydroartemisinin-mediated killing, such that E1 inhibition antagonizes artemisinin activity (PMID:30228310, PMID:32569299). Beyond these roles, the substrate repertoire and the mechanism governing dual apicoplast/cytosolic partitioning have not been characterized in the available corpus.

1. 2009 Medium

   Establishing where the parasite E1 enzyme acts was the first step; imaging placed PfsUba1 at the apicoplast, raising the possibility of an organelle-associated ubiquitylation system distinct from the canonical cytosolic pathway.

   Evidence GFP-fusion transfection and fluorescence imaging of full-length PfsUba1 in P. falciparum

   PMID:19502583

   Open questions at the time

   • Localization from a single method and lab
   • No enzymatic activity demonstrated at this stage
   • Cytosolic pool not yet distinguished
2. 2012 Medium

   Whether the enzyme is catalytically functional and where it operates in the ubiquitin-proteasome pathway was addressed by showing in vitro ubiquitylation activity and cytosolic localization within the ERAD system.

   Evidence In vitro ubiquitylation assay and immunofluorescence microscopy in P. falciparum

   PMID:22912882

   Open questions at the time

   • Relationship between cytosolic and apicoplast pools unresolved
   • Specific ERAD substrates not identified
   • No genetic essentiality data
3. 2013 High

   The functional consequence of the apicoplast pool was resolved by conditional ablation and complementation, establishing that the biochemically active enzyme is required for import of nuclear-encoded plastid proteins and for parasite survival.

   Evidence In vitro reconstitution, conditional gene ablation, complementation, and apicoplast protein import assay in P. falciparum and T. gondii

   PMID:23785288

   Open questions at the time

   • Molecular mechanism coupling ubiquitin activation to plastid import unclear
   • Substrate proteins of the import-linked ubiquitylation not defined
4. 2018 Medium

   The enzyme's placement in the artemisinin killing pathway was defined by chemical-genetic epistasis, showing E1 inhibition depletes polyubiquitinated proteins and antagonizes dihydroartemisinin, positioning E1 upstream of the polyubiquitin accumulation that mediates drug lethality.

   Evidence Pharmacological E1 inhibition combined with DHA treatment; polyubiquitin and ER stress marker readouts in P. falciparum

   PMID:30228310

   Open questions at the time

   • Inhibitor specificity for E1 not fully excluded
   • Identity of the artemisinin-damaged substrates unknown
5. 2020 High

   The blood-stage developmental requirement and druggability were established by conditional deletion causing a schizont-to-merozoite differentiation block and by potent in vitro inhibition of recombinant enzyme by MLN7243.

   Evidence Rapamycin-inducible conditional deletion, in vitro inhibition of recombinant PfUBA1, structural homology modeling, and ubiquitylation-site proteomics in P. falciparum

   PMID:32569299

   Open questions at the time

   • Structure is a homology model, not experimental
   • Downstream E2/E3 partners driving merozoite formation not defined
   • Direct substrates at the schizont transition not mapped

• How a single E1 enzyme is partitioned between the apicoplast and cytosol, and what substrate/E2-E3 networks it feeds in each compartment, remains open.
• Targeting/partitioning mechanism between compartments unknown
• No comprehensive substrate map
• Downstream ubiquitin conjugation partners uncharacterized in the corpus